20/20 BioResponse, which produces BioCheck Suspicious Powder Screening Kits, is a division of 20/20 GeneSystems, Inc, a biotech R&D company, specializing in the development of protein based cancer diagnostic products. BioCheck was designed for responders specificically for ease of use, low cost and fast results, BioCheck functions as an initial biological screen by performing a highly sensitive positive protein test. Often used as the first step in conjunction with other sophisticated dection instrumentations, BioCheck was developed specifically to allow first responders to quickly rule out the presense of any biological pathagen and quickly restore confidence, preventing widescale evacuations. Highly endorsed by civil first resonders and military CBRN teams worldwide, BioCheck is a favored technology when dealing with unidentified powders during suspicious powder incidents and hoax mailing threats. Useful for responder agencies for large federal or military organizations as well as smaller civilian municipalities, its low cost and short training requirements make it a favored tool for all agencies regardless of size or budget. BioCheck has been extensively tested and evaluated by leading university and US DOD laboratories. BioCheck has been shown to detect minute amounts of biological materal in unknown powders. Based in the Washington, DC area, 20/20 operates a state of the art laboratory with a full-time staff of biochemists and molecular biologists.